Navigation Links
Nutrastar International Inc. Announces Record Second Quarter 2010 Results

Nutrastar International Inc. Announces Record Second Quarter 2010 Results -- HARBIN, China, Aug. 16 /PRNewswire-Asia/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Food & Beverages, OTC, SmallCap, Biotechnology, Health Care & Hospitals, Earnings Forecasts & Projections, Earnings Click to view news release full screen  

Nutrastar International Inc. Announces Record Second Quarter 2010 Results


HARBIN, China, Aug. 16 /PRNewswire-Asia/ -- Nutrastar International Inc. (OTC Bulletin Board: NUIN; "Nutrastar" or the "Company"), a leading nutraceutical company which produces and distributes Chinese Golden Grass ("Cordyceps Militaris") and other specialty food products, today announced financial results for their three and six months ended June 30, 2010.

Financial Highlights for the Three Months Ended June 30, 2010: -- Revenues increase 63.4%; -- Gross margin increases 19.1% to 83.7% -- EPS reaches $0.12

Three Months Ended June 30, 2010

Revenues reached $5.46 million, an increase of approximately $2.12 million, or 63.4% from the same period in 2009. The increase was mainly attributable to the increase in sales of the company's core product, Chinese Golden Grass, as well as an increase in selling prices for their packaged Chinese Golden Grass products.

Gross profit was $4.57 million, an increase of approximately $2.41 million, or 112.0% as compared to the same period in 2009. Gross margin was 83.7%, an increase of 19.1% from 64.6% during the same period in 2009. The increase in gross margin was mainly due to continued product mix shift towards Chinese Golden Grass and increased sales of their higher margin small package Chinese Golden Grass products.

Operating income was approximately $3.79 million, an increase of $2.07 million, or up 120.3% from the comparable period of 2009. Operating margin was 69.4% for the second quarter 2010, an increase of 17.9% from 51.5% during the comparable 2009 period.

Net income was $3.42 million, an increase of $1.92 million, or 127.7% from the same period of 2009. Basic and diluted earnings per share for both quarters ended June 30, 2010 and 2009 was $0.12.

Six Months Ended June 30, 2010

Revenues were $10.23 million, an increase of 28.1% from approximately $7.98 million recorded for the same six month period in 2009. The increase was primarily as a result of an increase in sales of their Chinese Golden Grass, as well as an increase in selling prices for their packaged Chinese Golden Grass products.

Gross profit was recorded as $8.28 million, an increase of 64.2% from approximately $5.04 million during the same period in 2009. Gross margin was 81.0% for the six months ended June 30, 2010, an increase of 17.8% from 63.2% during the same period in 2009. As mentioned above, the increase was a result of continued product mix shift towards Chinese Golden Grass and the increased sales of their higher margin products.

Operating income was approximately $6.90 million, up 64.6% from $4.19 million recorded in the same six month period of 2009. Operating margin was 67.5% for the first six months of 2010, an increase of 15.0% from 52.5% recorded in the same six month period of 2009.

Net income was $6.14 million, up 67.2% from $3.67 million recorded in the first six months of 2009. Earnings per basic share was $0.31 and per diluted share was $0.30 as compared to $0.29 for the comparable 2009 period on a basic and diluted basis.

As of June 30, 2010, the Company had cash and cash equivalents in the amount of $32.26 million and total liabilities in the amount of $11.92 million.

Ms. Lianyun Han, President and Chief Executive Officer of Nutrastar commented, "Nutrastar's performance in the second quarter was exceptional. We saw heightened consumer demand for our Golden Grass products, especially our high margin, small packaged products. This significant increase in sales suggests that consumer knowledge of the medicinal benefits of Chinese Golden Grass is gaining traction and the nutraceutical market in China is growing at a healthy rate. On a quarterly basis, revenues increased by roughly 63.4% and EPS reached $0.12, outstanding growth given the current volatile economic environment."

Ms. Han continued, "Since the second quarter ended, we announced a few important measures that will prepare the company for significant expansion and growth in the time ahead. We plan to expand our manufacturing capabilities by over 30%, increasing our production capacity to 72 tons by the end of 2010. In addition to expanding our production capacity, we are also continuously seeking to further our geographical footprint and diversify our Golden Grass product pipeline. We announced in July 2010 the signing of a product purchase agreement with Century Brighton Holdings, which will further expand our customer base and penetration into the lucrative Hong Kong market. We also announced the patent application of our Golden Grass wine and oral liquids which we anticipate will be in trial production in Q1 2011. It's expected that with our increased production capabilities, continued efforts on the R&D side, as well as further expansion of distribution network, Nutrastar will show consistent growth on both the revenue side and product side going forward."

For more information regarding Nutrastar's financial performance during the second quarter of 2010, please refer to the Quarterly Report on Form 10-Q to be filed with the Securities and Exchange Commission on August 16, 2010.

NUTRASTAR INTERNATIONAL INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (AMOUNTS EXPRESSED IN US DOLLARS) June 30 December 31 2010 2009 (Unaudited) ASSETS CURRENT ASSETS Cash and cash equivalents $ 32,262,243 $ 20,115,677 Restricted cash 350,000 -- Accounts receivable 279,564 215,486 Inventories 704,502 616,073 Due from related party 51,000 -- Prepayments and other receivables 209,733 251,235 Total current assets 33,857,042 21,198,471 OTHER ASSETS Intangible assets, net 2,541,496 2,747,402 Property, plant and equipment, net 10,174,213 10,396,507 Total assets $ 46,572,751 $ 34,342,380 LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES Accounts payable $ 55,214 $ 863 Other payables and accruals 380,184 453,504 Payable for intangible assets 883,535 878,709 Income tax payable 241,032 319,873 Due to related parties 551,665 49,794 Preferred stock dividend payable 13,748 -- Acquisition payable 8,784,821 8,736,833 Total current liabilities 10,910,199 10,439,576 Warrants liabilities 1,006,279 -- Total liabilities 11,916,478 10,439,576 COMMITMENTS AND CONTINGENCIES SHAREHOLDERS' EQUITY Preferred Stock, $0.001 par value, 1,000,000 shares authorized, 197,706 shares and none shares issued and outstanding, respectively; aggregate liquidation preference amount: $5,535,768 and $nil, plus accrued but unpaid dividend of $13,748 and $nil, at June 30, 2010 and December 31, 2009, respectively 4,554,406 -- Common stock, $0.001 par value, 190,000,000 shares authorized, 14,332,731 and 14,297,731 shares issued and outstanding 14,333 14,298 Additional paid-in capital 6,356,116 4,715,891 Statutory reserves 1,345,894 1,341,687 Retained earnings 21,234,521 16,858,012 Accumulated other comprehensive income 1,151,003 972,916 Total shareholders' equity 34,656,273 23,902,804 Total liabilities and shareholders' equity $ 46,572,751 $ 34,342,380 CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (UNAUDITED) (AMOUNTS EXPRESSED IN US DOLLARS) For the Three Months For the Six Months Ended June 30, Ended June 30, 2010 2009 2010 2009 Revenue $5,458,152 $3,339,762 $10,226,547 $7,983,039 Cost of goods sold (888,415) (1,183,805) (1,944,930) (2,939,751) Gross profit 4,569,737 2,155,957 8,281,617 5,043,288 Selling expenses (233,310) (81,574) (405,028) (193,119) General and administrative expenses (547,331) (354,696) (977,117) (658,211) Income from operations 3,789,096 1,719,687 6,899,472 4,191,958 Other income (expenses): Interest income 33,719 39,849 66,796 52,584 Exchange loss (15,698) (5,109) (15,269) (3,509) Change in fair value of warrants 131,088 -- 131,088 -- Other -- -- -- 152 Total other income(expenses) 149,109 34,740 182,615 49,227 Income before income tax 3,938,205 1,754,427 7,082,087 4,241,185 Provision for income tax (522,564) (254,620) (945,384) (570,838) Net income 3,415,641 1,499,807 6,136,703 3,670,347 Other comprehensive income: Foreign currency translation adjustment 169,229 13,628 178,087 9,317 Total comprehensive income $3,584,870 $1,513,435 $6,314,790 $3,679,664 Earnings per share: Basic $0.12 $0.12 $0.31 $0.29 Diluted $0.12 $0.12 $0.30 $0.29 Weighted average number of shares outstanding: Basic 14,332,731 12,874,654 14,322,786 12,836,405 Diluted 14,342,168 12,874,654 14,445,374 12,836,405

About Nutrastar International Inc.

Nutrastar International Inc. is a China based nutraceutical company which produces and distributes Chinese Golden Grass ("Cordyceps Militaris"), organic and specialty food products in China. The Company's primary product is dry engineered Chinese Golden Grass, which is one of the most highly regarded herbal nutrients in Chinese culture. The Company believes it is the largest manufacturer of engineered Chinese Golden Grass in China, ranked by volume, according to China Market Monitoring Center (CMMC), accounting for 19% market share in China. The Company is headquartered in Harbin, capital of Heilongjiang province, with 302 employees, 21 in R&D, and 132 in sales and marketing. The products of Nutrastar are sold throughout China via a distribution network that covers more than 10 provinces. More information may be found at or e-mail:

Safe Harbor Statement

This news release contains "forward-looking statements" relating to the business of Nutrastar International Inc. and its subsidiary companies. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These forward-looking statements are often identified by the use of forward- looking terminology such as "believes," "expects" or similar expressions. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. . You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, the Company does not assume a duty to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact: Robert Tick, CFO Nutrastar International Inc. Tel: +1-408-306-9881 Email: Howard Gostfrand American Capital Ventures Tel: +1-305-918-7000 Email:

SOURCE Nutrastar International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Nutrastar International, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing
2. International Society for Cellular Therapy (ISCT) joins forces with Roche and Genzyme to launch Cell Therapy Industry Partnership.
3. Dyadic International to Announce Second Quarter 2010 Financial Results and Hold Conference Call on August 13, 2010
4. Dyadic International Announces Final Resolution and Dismissal of Stockholder Class Action Lawsuit
5. Renhuang Receives AAA(1) Rating from Chinese Academy of International Trade & Economic Cooperation of Ministry of Commerce
6. SemBioSys Appoints President of US and International Operations and Announces the Appointments of Three Vice Presidents
7. FRC Systems International State-of-the-art Industrial Wastewater Treatment Systems
8. Yongye International Expands Its Existing Production Capacity by 50% and Provides Updates on Customer List Acquisition
9. Bacterin International Appoints Three New Members to Its Board of Directors
10. THE PLANNING SHOP international Announces Oncology Business Unit
11. Dyadic International Engages The Abraham Group as Strategic Advisor
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... ... the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life, ... in analytical testing are being attributed to new regulatory requirements for all new ...
(Date:10/11/2017)... ... 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th ... in San Francisco, CA. The Summit brings together current and former FDA office bearers, ... and government officials from around the world to address key issues in device compliance, ...
(Date:10/11/2017)... ... October 11, 2017 , ... A ... pregnancy rates in frozen and fresh in vitro fertilization (IVF) transfer ... age to IVF success. , After comparing the results from the fresh and ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder ... local San Diego Rotary Club. The event entitled “Stem Cells and ... had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: ...
Breaking Biology Technology:
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
(Date:4/6/2017)... , April 6, 2017 Forecasts ... ANPR, Document Readers, by End-Use (Transportation & Logistics, Government ... Oil, Gas & Fossil Generation Facility, Nuclear Power), Industrial, ... Other) Are you looking for a definitive ... ...
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
Breaking Biology News(10 mins):